Drug Trial Radar · NCT04597359
To Evaluate if Green Tea Can be Effective in Reducing the Progression of Prostate Cancer in Men on Close Monitoring
Last checked: Nov 19, 2026Latest source record: Sep 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
360
Planned (sponsor's estimate)
Start
Oct 5, 2021
Primary completion
Dec 31, 2026
Study completion Dec 31, 2027
Sponsor
- Lead sponsor
- ECOG-ACRIN Cancer Research GroupResearch network
- Sponsor type
- Research network
- Collaborators
- National Cancer Institute (NCI)
- First posted
- Oct 22, 2020
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Prevention
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 21 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This phase II trial studies how well green tea catechins work in preventing progression of prostate cancer from a low risk stage to higher risk stages in men who are on active surveillance. Green tea catechins may stabilize prostate cancer and lower the chance of prostate growing.
Conditions
- Prostate Carcinoma
Interventions
Placebo AdministrationDrug
Given PO
Quality-of-Life AssessmentOther
Ancillary studies
Questionnaire AdministrationOther
Ancillary studies
SinecatechinsDrug
Given PO
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in the highest percent Ki-67 expressionTime frame: Baseline to 6 months
Locations
353 sites in 3 countries. Site status is shown where the registry gives one.
Fairbanks Memorial Hospital
Fairbanks, Alaska
Cancer Center at Saint Joseph's
Phoenix, Arizona
Highlands Oncology Group - Fayetteville
Fayetteville, Arkansas
Mercy Hospital Fort Smith
Fort Smith, Arkansas
CHI Saint Vincent Cancer Center Hot Springs
Hot Springs, Arkansas
CARTI Cancer Center
Little Rock, Arkansas
Highlands Oncology Group - Rogers
Rogers, Arkansas
Highlands Oncology Group
Springdale, Arkansas
Mission Hope Medical Oncology - Arroyo Grande
Arroyo Grande, California
Marshall Cancer Center
Cameron Park, California
Mercy Cancer Center - Carmichael
Carmichael, California
Mercy San Juan Medical Center
Carmichael, California
Epic Care-Dublin
Dublin, California
Mercy Cancer Center - Elk Grove
Elk Grove, California
Bay Area Breast Surgeons Inc
Emeryville, California
Epic Care Partners in Cancer Care
Emeryville, California
UC San Diego Health System - Encinitas
Encinitas, California
UC San Diego Moores Cancer Center
La Jolla, California
Contra Costa Regional Medical Center
Martinez, California
Mercy Cancer Center
Merced, California
Alta Bates Summit Medical Center - Summit Campus
Oakland, California
Bay Area Tumor Institute
Oakland, California
Marshall Hospital
Placerville, California
Mercy Cancer Center - Rocklin
Rocklin, California
Mercy Cancer Center - Sacramento
Sacramento, California
UC San Diego Medical Center - Hillcrest
San Diego, California
Pacific Central Coast Health Center-San Luis Obispo
San Luis Obispo, California
UCSF Cancer Center - San Mateo
San Mateo, California
Mission Hope Medical Oncology - Santa Maria
Santa Maria, California
Epic Care Cyberknife Center
Walnut Creek, California
BASS Medical Group - Lennon
Walnut Creek, California
Woodland Memorial Hospital
Woodland, California
Rocky Mountain Cancer Centers-Aurora
Aurora, Colorado
Rocky Mountain Regional VA Medical Center
Aurora, Colorado
UCHealth University of Colorado Hospital
Aurora, Colorado
Boulder Community Foothills Hospital
Boulder, Colorado
Rocky Mountain Cancer Centers-Boulder
Boulder, Colorado
Rocky Mountain Cancer Centers - Centennial
Centennial, Colorado
Penrose-Saint Francis Healthcare
Colorado Springs, Colorado
Rocky Mountain Cancer Centers-Penrose
Colorado Springs, Colorado
Showing 40 of 353 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.